Video Series: Dr. Dotters-Katz weighs in on COVID-19 in pregnancy
Dr. Sarah Dotters-Katz is a maternal-fetal medicine specialist and obstetrician and gynecologist at Duke Health in Durham, N.C. One of her research interests is clinical infectious diseases and how they impact pregnancy.
Dr. Sarah Dotters-Katz is a maternal-fetal medicine specialist and obstetrician and gynecologist at Duke Health in Durham, N.C. One of her research interests is clinical infectious diseases and how they impact pregnancy.
In this video, Dr. Dotters-Katz discusses her perspective on COVID-19’s impact on pregnant patients with Senior Editor Angie DeRosa. Dotters-Katz also includes what she is seeing in her area of the United States. She has been very active in spreading her knowledge. She wrote a commentary in the April issue of Contemporary OB/GYN with Dr. Brenna Hughes, entitled, “COVID-19: The pathogen that will define the decade.”
She and Dr. Hughes also did a review recently for the American Journal of Perinatology, “Considerations for obstetric care during the COVID-19 pandemic,” in which they discussed the key points that COVID-19 severity in pregnancy is unclear and social distancing is the best protective mechanism. There is no clear evidence that vertical transmission exists. If a mother is positive, then mother/ baby separation avoids transmission. That article abstract can be found here.
Mosie Baby Kit receives class 2 FDA clearance for intravaginal insemination
December 6th 2023Discover how Mosie Baby's at-home insemination kit, the first FDA-cleared of its kind, empowers individuals facing infertility challenges with an effective, easy-to-use solution for intravaginal insemination.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Exploring menstrual health: Insights from the Avon longitudinal study
December 5th 2023Unveiling a comprehensive analysis of menstrual cycle characteristics in mothers and daughters, this article delves into the diverse features, potential risk factors, and the importance of understanding these nuances for effective menstrual health management.
Read More
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen
Integrating pharmacists into PPHTN management for enhanced blood pressure control
December 4th 2023A study reveals that involving pharmacists in the care of postpartum women at risk of persistently elevated blood pressure, as presented at the American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting and Exhibition, can provide an effective and feasible solution to managing hypertensive disorders, reducing postpartum readmission risks, and improving overall health care access.
Read More
